2 completed, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Unknown 1 |
Follow JPI-289: new trials by email Literature Review of JPI-289 trials Research Report on JPI-289
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke JPI-289 Low-dose, JPI-289 High-dose, Placebo - Acute Ischemic Stroke | Phase 2 | Unknown | Jeil Pharmaceutical Co., Ltd. | 110 | 2016-12-09 | 2019-11-18 |
| The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers JPI-289, Placebo - Stroke | Phase 1 | Completed | Jeil Pharmaceutical Co., Ltd. | 24 | 2015-03-01 | 2016-06-24 |
| The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers JPI-289, Placebo - Stroke | Phase 1 | Completed | Jeil Pharmaceutical Co., Ltd. | 40 | 2013-11-01 | 2016-06-24 |
Stroke (2) · Ischemic Stroke (1)
Jeil Pharmaceutical Co., Ltd. (3)
South Korea (3)
Hyeong-Seok Lim, M.D.,Ph.D. (1) · HyeongSeok Lim, M.D.,Ph.D. (1)